Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	38.28	69.91	50.56
Graham Fair Price	-22.36	10845.20	13967.77
PEG	1909.63	0.36	-0.02
Price/Book	-11.28	1.21	1.37
Price/Cash Flow	-22.39	25.32	-32.63
Prices/Earnings	-37.93	-13.53	-9.81
Price/Sales	-24.37	1.43	1.89
Price/FCF	-22.39	25.32	-32.63
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	6.12	0.03	-0.03
Operating Margin	26.85	-0.03	-0.03
ROA	37.74	< 0.005	-0.01
ROE	-0.03	-0.02	35.67
ROIC	-0.01	< 0.005	34.15
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.11	-0.04	208.78
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-9.17	0.17	-98.15
EPS QOQ	-5.50	0.38	-93.14
FCF QOQ	-73.87	2.11	-97.15
Revenue QOQ	-0.11	0.14	25.59
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	36.79	28.54	-22.42
Days Sales Outstanding (DSO)	63.41	54.62	-13.85
Inventory Turnover	2.45	3.15	28.90
Debt/Capitalization	0.38	0.41	8.63
Quick Ratio	1.58	1.57	-0.64
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15784.00	15280.29	-3.19
Cash	5995.68	7127.49	18.88
Capex	-650.23	-439.50	32.41
Free Cash Flow	-660.45	730.98	10.68
Revenue	11416.93	12965.82	13.57
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.15	2.03	-5.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.34	19.48	71.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating